M
MCK
MCKReviewed5 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$360.1B16.5%
FY2025
Operating Segments
5Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%USPharmaceutical
Segment Shift
USPharmaceutical has grown from 0.0% to 91.0% of total revenue since FY2019, with 0.0% operating margins. Meanwhile, U.S.Pharmaceuticaland Specialty Solutions is the fastest growing at +1000.0% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| USPharmaceutical | $327.7B | $0 | 0.0% | 91.0% | +17.6% |
| International | $14.7B | $0 | 0.0% | 4.1% | +4.2% |
| Medical Surgical Solutions | $11.4B | $0 | 0.0% | 3.2% | +0.6% |
| Prescription Technology Solutions | $5.2B | $0 | 0.0% | 1.4% | +9.4% |
| U.S.Pharmaceuticaland Specialty Solutions | $1.1B | $0 | 0.0% | 0.3% | +1000.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free